- 专利标题： DEVELOPMENT OF PRMT-TARGETING THERAPY TO ENHANCE EGFR-TARGETING DRUG EFFICACY IN NSCLC
-
申请号： US18547871申请日： 2022-02-25
-
公开(公告)号： US20240299356A1公开(公告)日： 2024-09-12
- 发明人: Steven ALTSCHULER , Lani WU , Xiaoxiao SUN , Matthew JACOBSON
- 申请人： The Regents of the University of California
- 申请人地址： US CA Oakland
- 专利权人： The Regents of the University of California
- 当前专利权人： The Regents of the University of California
- 当前专利权人地址： US CA Oakland
- 国际申请： PCT/US2022/018023 2022.02.25
- 进入国家日期： 2023-08-24
- 主分类号： A61K31/415
- IPC分类号： A61K31/415 ; A61K31/40 ; A61K31/506 ; A61K31/517 ; A61K31/555 ; A61K31/7068
摘要：
Provided herein are, inter alia, methods and composition for the treatment of cancers that are recalcitrant to treatment and/or become resistant to certain drug treatments. The methods provided may, inter alia, be used to treat cancer in subjects having elevated STAT1 activity levels.
信息查询
